Daiwa Securities Group Inc. Has $6.29 Million Holdings in Molina Healthcare, Inc $MOH

Daiwa Securities Group Inc. lowered its stake in Molina Healthcare, Inc (NYSE:MOH) by 10.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 36,233 shares of the company’s stock after selling 4,401 shares during the period. Daiwa Securities Group Inc. owned approximately 0.07% of Molina Healthcare worth $6,287,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in MOH. Torren Management LLC acquired a new stake in shares of Molina Healthcare in the fourth quarter worth about $26,000. Miller Global Investments LLC acquired a new stake in shares of Molina Healthcare in the fourth quarter worth about $27,000. Cromwell Holdings LLC lifted its position in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after buying an additional 125 shares during the last quarter. Rakuten Securities Inc. lifted its position in shares of Molina Healthcare by 5,020.0% in the fourth quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock worth $44,000 after buying an additional 251 shares during the last quarter. Finally, MUFG Securities EMEA plc acquired a new stake in shares of Molina Healthcare in the second quarter worth about $48,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Stock Up 0.2%

MOH stock opened at $191.16 on Monday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $311.52. The company has a 50-day moving average of $168.40 and a two-hundred day moving average of $162.57. The stock has a market capitalization of $9.96 billion, a price-to-earnings ratio of 56.56 and a beta of 0.80.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The company had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. During the same period in the prior year, the company earned $6.08 earnings per share. The business’s quarterly revenue was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities research analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Activity

In related news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have weighed in on MOH shares. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a research report on Friday, March 13th. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target for the company in a research report on Wednesday, April 29th. UBS Group boosted their price target on Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, May 22nd. TD Cowen decreased their price target on shares of Molina Healthcare from $175.00 to $144.00 and set a “hold” rating for the company in a report on Monday, February 9th. Finally, Cantor Fitzgerald upped their price target on shares of Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $179.93.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.